Ono Pharmaceuticals starts human microdose studies at patients’ home

Microdoses are defined by choosing concentrations which initiate neither pharmaceutical nor toxic activity. The tests are done on healthy persons and relate to absorption, pharmacokinetics etc., in the framework of a NEDO programme which aims at simplified and faster tests to promote the development of new drugs from Japan

Ono Pharmaceuticals press release, Sept. 4, 2012

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny